Finch Therapeutics Group, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
FNCH on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
75 State Street, Suite 100, Boston, MA

Insiders trading volume in the past year

Finch Therapeutics Group, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Vittiglio Chief Business & Legal Officer $114K Oct 21, 2022
Jeffery Smisek Director $110K -$26.6K -19.4% Jun 7, 2024
Marc Blaustein Chief Operating Officer $102K Feb 21, 2023
Susan Graf Director $18.2K Jun 8, 2023
Christian H. Lange Director Jun 8, 2023
Domenic J. Ferrante Director Jun 8, 2023
Chris Shumway Director, 10%+ Owner Jun 8, 2023
Lance E. Thibault Chief Financial Officer May 16, 2023
Gregory D. Perry Chief Financial Officer Feb 25, 2022
Matthew P. Blischak Chief Executive Officer Jun 9, 2023
Samuel A. Hamood Director Jun 13, 2022
Joanne L. Viney Director Jun 13, 2022
Nicholas Haft Director Jun 8, 2023

Recent Insider Transactions by Companies or Individuals for Finch Therapeutics Group, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.